Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Belatacept on the Pharmacokinetics of Inje Cocktail in Healthy Subjects
NCT01766050Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2013
- Primary completion
- Apr 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of belatacept in transplant rejection, sponsored by Bristol Myers Squibb. Started Jan 2013; status: completed.
02
Drugs
belatacept
03
Conditions
transplant rejection
Beyond the preview
Go deeper on NCT01766050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766050.